rts logo

Biodexa Pharmaceuticals Plc ADR (BDRX) Stock Could Soon Reward Patient Investors

Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) is -45.52% lower on its value in year-to-date trading and has touched a low of $0.72 and a high of $45.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BDRX stock was last observed hovering at around $1.62 in the last trading session, with the day’s loss setting it -0.16%.

Currently trading at $1.46, the stock is 23.83% and 2.07% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.54 million and changing -9.88% at the moment leaves the stock -60.30% off its SMA200. BDRX registered -96.16% loss for a year compared to 6-month loss of -71.43%. The firm has a 50-day simple moving average (SMA 50) of $0.46 and a 200-day simple moving average (SMA200) of -$0.03.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a 14.96% gain in the last 1 month and extending the period to 3 months gives it a -44.49%, and is 39.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 27.94% over the week and 11.05% over the month.

Profit margin for the company is -1533.60%. Distance from 52-week low is 102.98% and -96.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-135.68%).

Biodexa Pharmaceuticals Plc ADR quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $240k over the same period.

Biodexa Pharmaceuticals Plc ADR (BDRX) Top Institutional Holders

14 institutions hold shares in Biodexa Pharmaceuticals Plc ADR (BDRX), with institutional investors hold 37.57% of the company’s shares. Institutions hold 31.32% of the Float.

The top institutional shareholder in the company is Cubist Systematic Strategies, LLC with over 3325.0 shares valued at $228.0. The investor’s holdings represent 1.41% of the BDRX Shares outstanding. As of Jun 29, 2023, the second largest holder is Millennium Management Llc with 2554.0 shares valued at $175.0 to account for 1.08% of the shares outstanding. The other top investors are UBS Group AG which holds 1778.0 shares representing 0.75% and valued at over $121.0, while Two Sigma Securities, LLC holds 0.20% of the shares totaling 473.0 with a market value of $32.0.

Related Posts